Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models
Thierry Menguy(Cherry Biotech (France)), Philippe Le Bouteiller(Inserm)
Cited by 10
Related Papers
BCR/ABL Oncogene Directly Controls MHC Class I Chain-Related Molecule A Expression in Chronic Myelogenous Leukemia
|The Journal of Immunology|2006|142